A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome

BACKGROUND: Phelan-McDermid syndrome (PMS) is a rare neurodevelopmental disorder caused by haploinsufficiency of the SHANK3 gene and characterized by global developmental delays, deficits in speech and motor function, and autism spectrum disorder (ASD). Monogenic causes of ASD such as PMS are well s...

Descripción completa

Detalles Bibliográficos
Autores principales: Fastman, J., Foss-Feig, J., Frank, Y., Halpern, D., Harony-Nicolas, H., Layton, C., Sandin, S., Siper, P., Tang, L., Trelles, P., Zweifach, J., Buxbaum, J. D., Kolevzon, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482590/
https://www.ncbi.nlm.nih.gov/pubmed/34593045
http://dx.doi.org/10.1186/s13229-021-00459-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482590/
https://www.ncbi.nlm.nih.gov/pubmed/34593045
http://dx.doi.org/10.1186/s13229-021-00459-1

Ejemplares similares